Form 4: Edgewise Therapeutics CSO Alan J. Russell Executes Stock Option and Sells Shares
SEC Form 4
Alan J. Russell, Chief Scientific Officer of Edgewise Therapeutics, exercised stock options and sold shares on September 20, 2024.
Summary
- On September 20, 2024, Alan J. Russell, the Chief Scientific Officer of Edgewise Therapeutics, exercised stock options to acquire 75,000 shares of common stock at a price of $0.18 per share.
- He then sold 74,185 shares at an average price of $28.2544 and 815 shares at an average price of $29.5074.
- Following these transactions, Russell directly owns 12,719 shares of common stock and holds options for 1,456,780 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of stock transactions. The transactions themselves don't necessarily indicate a positive or negative outlook for the company.
Industry Context
This Form 4 filing is a routine disclosure of insider transactions, providing transparency to investors regarding the actions of company executives.
Stakeholder Impact
- The transactions may have a minor impact on shareholders due to the change in ownership, but the overall effect is likely minimal.
Key Dates
| Date | Description |
|---|---|
| 06/27/2017 | 1/48th of the shares subject to the option vested each month beginning on this date. |
| 05/15/2023 | Purchase of 2,968 shares pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. |
| 11/15/2023 | Purchase of 2,088 shares pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. |
| 05/15/2024 | Purchase of 425 shares pursuant to the Edgewise Therapeutics, Inc. 2021 Employee Stock Purchase Plan. |
| 09/20/2024 | Earliest transaction date: Exercise of stock options and sale of shares. |
| 09/20/2024 | Attorney-in-Fact signed the document. |
| 06/27/2032 | Expiration date of the stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.